JP5865839B2 - 粘膜アジュバント組成物 - Google Patents
粘膜アジュバント組成物 Download PDFInfo
- Publication number
- JP5865839B2 JP5865839B2 JP2012536205A JP2012536205A JP5865839B2 JP 5865839 B2 JP5865839 B2 JP 5865839B2 JP 2012536205 A JP2012536205 A JP 2012536205A JP 2012536205 A JP2012536205 A JP 2012536205A JP 5865839 B2 JP5865839 B2 JP 5865839B2
- Authority
- JP
- Japan
- Prior art keywords
- mucosal
- vaccine
- canine
- infection
- transmucosal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
本発明は、ボルデテラ・ブロンキセプティカの菌体又はその培養液から得られた分子量30〜500kDaの組成物であり、粘膜アジュバント活性を有するものを少なくとも含有する粘膜アジュバント組成物を全て包含する。
本発明に係る経粘膜感染症予防用ワクチン製剤は、経粘膜感染症に対するワクチンと、上述の粘膜アジュバント組成物とを少なくとも含有するものをすべて包含する。
例えば、経粘膜感染症に対する単独又は混合のワクチンと、上述の粘膜アジュバント組成物とを同時に又は個別に投与することにより、非ヒト動物経粘膜感染症を有効に予防できる。
Claims (8)
- ボルデテラ・ブロンキセプティカの菌体又はその培養液から得られた分子量100〜300kDaの組成物を少なくとも含有する粘膜アジュバント組成物。
- 前記組成物が赤血球凝集素を有効成分として含有する請求項1記載の粘膜アジュバント組成物。
- 経粘膜感染症に対するワクチンと、請求項1記載の粘膜アジュバント組成物とを少なくとも含有する経粘膜感染症予防用の粘膜ワクチン製剤。
- 前記経粘膜感染症が犬パラインフルエンザウイルス、犬アデノウイルス、犬コロナウイルス、犬パルボウイルス、犬ジステンパーウイルス、犬ヘルペスウイルス、レオウイルス、ニューモウイルスのいずれか又は複数の感染を少なくとも含むものである請求項3記載の経粘膜感染症予防用の粘膜ワクチン製剤。
- 前記経粘膜感染症が犬伝染性気管気管支炎である請求項3記載の経粘膜感染症予防用の粘膜ワクチン製剤。
- 経粘膜感染症に対する単独又は混合のワクチンと、ボルデテラ・ブロンキセプティカの菌体又はその培養液から得られた分子量100〜300kDaの組成物を少なくとも含有する粘膜アジュバント組成物とを投与する非ヒト動物経粘膜感染症予防方法。
- ボルデテラ・ブロンキセプティカの菌体又はその培養液から得られた分子量100〜300kDaの組成物の、粘膜アジュバント組成物製造のための使用。
- ボルデテラ・ブロンキセプティカの菌体又はその培養液から得られた分子量100〜300kDaの組成物を調製する手順を少なくとも含む粘膜アジュバント組成物製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012536205A JP5865839B2 (ja) | 2010-09-28 | 2011-09-27 | 粘膜アジュバント組成物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010216963 | 2010-09-28 | ||
JP2010216963 | 2010-09-28 | ||
JP2012536205A JP5865839B2 (ja) | 2010-09-28 | 2011-09-27 | 粘膜アジュバント組成物 |
PCT/JP2011/005438 WO2012042857A1 (ja) | 2010-09-28 | 2011-09-27 | 粘膜アジュバント組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2012042857A1 JPWO2012042857A1 (ja) | 2014-02-06 |
JP5865839B2 true JP5865839B2 (ja) | 2016-02-17 |
Family
ID=45892346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012536205A Active JP5865839B2 (ja) | 2010-09-28 | 2011-09-27 | 粘膜アジュバント組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9381241B2 (ja) |
EP (1) | EP2623118A4 (ja) |
JP (1) | JP5865839B2 (ja) |
CN (1) | CN103153337A (ja) |
WO (1) | WO2012042857A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101380740B1 (ko) * | 2012-06-29 | 2014-04-11 | 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 | 이듀로네이트-2-설파타제의 정제 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5883629A (ja) * | 1981-11-10 | 1983-05-19 | Biseibutsu Kagaku Kenkyusho:Kk | アジュバント |
JPS59157029A (ja) * | 1983-02-28 | 1984-09-06 | Biseibutsu Kagaku Kenkyusho:Kk | 動物用・住血原虫病不活化ワクチン |
JP2003535147A (ja) * | 2000-06-07 | 2003-11-25 | アンスティトゥー パストゥール ド リール | 遊離形態でfhaタンパク質又はそのフラグメントを含むアジュバント組成物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1297845B1 (en) | 1994-06-10 | 2009-06-03 | Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute | Combination vaccine comprising toxoid of dermonecrotic toxin produced by Bordetella bronchiseptica |
JP2969147B2 (ja) | 1996-07-24 | 1999-11-02 | 農林水産省家畜衛生試験場長 | 気管支敗血症菌由来シアル酸特異的赤血球凝集素及びその精製法 |
AU769539B2 (en) * | 1999-01-29 | 2004-01-29 | Zoetis Services Llc | Adjuvants for use in vaccines |
US20050089533A1 (en) | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
KR20050103215A (ko) * | 2003-01-29 | 2005-10-27 | 화이자 프로덕츠 인코포레이티드 | 보르데텔라 브론키셉티카에 대한 개 백신 |
WO2006106424A2 (en) | 2005-04-07 | 2006-10-12 | Pharmacia & Upjohn Company Llc | Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines |
-
2011
- 2011-09-27 WO PCT/JP2011/005438 patent/WO2012042857A1/ja active Application Filing
- 2011-09-27 CN CN2011800463313A patent/CN103153337A/zh active Pending
- 2011-09-27 EP EP11828423.1A patent/EP2623118A4/en not_active Ceased
- 2011-09-27 JP JP2012536205A patent/JP5865839B2/ja active Active
- 2011-09-27 US US13/876,439 patent/US9381241B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5883629A (ja) * | 1981-11-10 | 1983-05-19 | Biseibutsu Kagaku Kenkyusho:Kk | アジュバント |
JPS59157029A (ja) * | 1983-02-28 | 1984-09-06 | Biseibutsu Kagaku Kenkyusho:Kk | 動物用・住血原虫病不活化ワクチン |
JP2003535147A (ja) * | 2000-06-07 | 2003-11-25 | アンスティトゥー パストゥール ド リール | 遊離形態でfhaタンパク質又はそのフラグメントを含むアジュバント組成物 |
Non-Patent Citations (4)
Title |
---|
JPN6011065527; CAN.J.COMP.MED. VOL.49, 1985, P.91-94 * |
JPN6011065529; 動物衛生試験研究成績・計画概要集 平成14年度 , 2003, P.291-292 * |
JPN6011065530; 動物衛生試験研究成績・計画概要集 平成14年度 , 2003, P.295-296 * |
JPN6015022596; EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS VOL.63, 2006, P.215-220 * |
Also Published As
Publication number | Publication date |
---|---|
EP2623118A1 (en) | 2013-08-07 |
JPWO2012042857A1 (ja) | 2014-02-06 |
EP2623118A4 (en) | 2014-05-07 |
CN103153337A (zh) | 2013-06-12 |
WO2012042857A1 (ja) | 2012-04-05 |
US9381241B2 (en) | 2016-07-05 |
US20130302360A1 (en) | 2013-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI272105B (en) | Cattle reproduction vaccines | |
KR101315092B1 (ko) | 로소니아 인트라셀룰라리스를 포함하는 면역원성 조성물 | |
ES2709190T3 (es) | Composiciones de vacuna contra el virus de la diarrea viral bovina tipo 1B y procedimientos | |
KR20040044942A (ko) | 수의 백신 보조제로서의 인터루킨-12 | |
BR112015012711B1 (pt) | Método para preparar uma composição imunogênica para o tratamento e/ou a profilaxia de infecções por mycoplasma | |
KR101654023B1 (ko) | 돼지유행성설사병바이러스 약독화주 및 불활화백신 조성물과 이를 이용한 경구 투여용 백신 조성물 | |
KR101442493B1 (ko) | 돼지유행성설사병바이러스 약독화주 및 이를 포함하는 돼지유행성 설사병 백신 조성물 | |
US9662382B2 (en) | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida | |
CN110227151B (zh) | 包含支原体抗原的免疫原性组合物 | |
JP2022506634A (ja) | 豚レンサ球菌感染防御のためのワクチン | |
EA037283B1 (ru) | Комбинированная вакцинная композиция для многократного дозирования | |
CN108066758B (zh) | 貉犬瘟热-细小病毒性肠炎二联活疫苗及其制备方法和用途 | |
DK2569007T3 (en) | VACCINE AGAINST Mycoplasma hyopneumoniae SUITABLE FOR ADMINISTRATION IN PRESENCE OF maternally derived antibodies | |
JP5847713B2 (ja) | 豚胸膜肺炎に対するワクチン及び当該ワクチンの取得方法 | |
CN1929859A (zh) | 抗睾丸bvdv感染的疫苗接种方法 | |
JP5865839B2 (ja) | 粘膜アジュバント組成物 | |
TW201718001A (zh) | 豬物種中增強之免疫反應 | |
TW201731526A (zh) | 混成核心之貓科動物疫苗 | |
RU2553222C2 (ru) | Композиции для лечения и предупреждения комплекса респираторных заболеваний собак | |
RU2546247C2 (ru) | Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак | |
KR102615970B1 (ko) | 소에서 설사병을 유발하는 바이러스에 대한 고도면역혈청, 이를 포함하는 조성물, 이의 제조 방법, 및 이를 이용한 소 바이러스성 설사병의 예방 및 치료 방법 | |
RU2395297C1 (ru) | Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи и лептоспироза крупного рогатого скота | |
RU2292220C1 (ru) | Способ профилактики инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота | |
AE El-Shamandy et al. | Efficacy of Lyophilized Inactivated Rabies Vaccine | |
EP2076280B1 (en) | Feline influenza vaccine and method of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140627 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150608 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150805 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151215 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151228 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5865839 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |